No definition available.
Drug-induced systemic lupus erythematosus
DRUGADVERS_SYSTEMIC_LUPUS_ERYTHEMAT
Endpoint definition
↥
Endpoint definition steps |
FinnGen |
|---|---|
Phenotype data |
520210 |
1. Apply sex-specific ruleNone |
520210 |
2. Check conditionsNone |
520210 |
3. Check pre-conditions, main-only, mode, registry filtersRegistry filters:
1 out of 7 registries used, show all original rules. |
239 |
4. Check minimum number of eventsNone |
239 |
5. Include endpointsNone |
239 |
6. Filter based on genotype QC (FinnGen only) |
239 |
Control definitions (FinnGen only)
Controls for this endpoint are individuals that are not cases.
Extra metadata
- Level in the ICD hierarchy
- C
- First used in FinnGen datafreeze
- DF5
Similar endpoints
↥List of similar endpoints to
Drug-induced systemic lupus erythematosus
based on the number of shared cases.
Similar with more cases:
- Systemic lupus erythematosus
- SLE (Finngen)
- Systemic connective tissue disorders
- Autoimmune diseases related-to ILD
- Finngen Rheumatological endpoints
Similar with less cases:
None
Case counts by codes
↥
Summary Statistics
↥-FinRegistry-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | |||
| Whole population | 1257 | 1021 | 229 |
| Only index persons | 1098 | 918 | 180 |
| Unadjusted period prevalence (%) | |||
| Whole population | 0.02 | 0.03 | 0.01 |
| Only index persons | 0.03 | 0.03 | 0.01 |
| Median age at first event (years) | |||
| Whole population | 52.81 | 51.34 | 58.87 |
| Only index persons | 50.83 | 49.95 | 55.29 |
-FinnGen-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | 239 | 201 | 38 |
| Unadjusted period prevalence (%) | 0.06 | 0.07 | 0.02 |
| Median age at first event (years) | 46.86 | 46.11 | 50.86 |
-FinRegistry-
Age distribution of first events
-FinnGen-
Age distribution of first events
-FinRegistry-
Year distribution of first events
-FinnGen-
Year distribution of first events
-FinRegistry-
Cumulative Incidence Function
-FinnGen-
Cumulative Incidence Function
No data
CodeWAS (R11)
↥CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.
This is a new tool, please reach out using the contact form for feedback and improvement ideas.
First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.
Matched cohort
- Matched cases
- 226
- Matched controls
- 2258
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
M32.0
ICD-10 Finland
Drug-induced systemic lupus erythematosus
+∞
323.0
225
*
M32.9
ICD-10 Finland
Systemic lupus erythematosus, unspecified
1482.2
213.1
175
5
P01BA02
ATC
hydroxychloroquine; oral
68.7
141.3
170
95
202
Kela drug reimbursment
Connective tissue diseases, rheumatoid arthritis and comparable disease
39.7
114.4
159
127
M32.8
ICD-10 Finland
Other forms of systemic lupus erythematosus
1320.2
92.7
84
*
M32.1
ICD-10 Finland
Systemic lupus erythematosus with organ or system involvement
+∞
88.5
79
*
L04AX01
ATC
azathioprine; systemic
30.9
67.3
92
49
M32
ICD-10 Finland
Systemic lupus erythematosus
553.8
47.1
45
*
NK4XE
NOMESCO Finland
Joint ultrasound examination not elsewhere classified
17.7
46.8
77
64
H02AB06
ATC
prednisolone; systemic
8.7
44.7
182
730
H02AB07
ATC
prednisone; oral
9.6
44.3
107
194
7100A
ICD-9 Finland
Diffuse diseases of connective tissue, Systemic lupus erythematosus
508.1
43.8
42
*
M35.9
ICD-10 Finland
Systemic involvement of connective tissue, unspecified
56.4
42.1
49
11
L04AA06
ATC
mycophenolic acid; systemic
48.9
41.8
50
13
A12AX
ATC
Calcium, combinations with vitamin D and/or other drugs
7.2
41.5
156
533
L04AX03
ATC
methotrexate; systemic (immunosuppressants)
11.9
37.4
74
89
M05BA04
ATC
alendronic acid; oral
11.8
36.4
72
86
L93.0
ICD-10 Finland
Discoid lupus erythematosus
374.2
32.8
32
*
M35.0
ICD-10 Finland
Sicca syndrome [Sjögren]
28.4
32.4
44
19
TNX10
NOMESCO Finland
Arthrocentesis, unspecified region, unspecified region
12.3
29.7
56
59
N08.5*M32.1
ICD-10 Finland
Glomerular disorders in systemic lupus erythematosus
+∞
28.8
27
*
NK6QA
NOMESCO Finland
Measurement of bone density from tow or more locations with X-ray
8.7
27.2
63
96
TQX10
NOMESCO Finland
Biopsy of skin and subcutaneous tissue
8.2
26.8
65
106
L01BA01
ATC
methotrexate; systemic (folic acid analog.)
14.9
25.9
44
36
73410
ICD-8 Finland
Diffuse diseases of connective tissue, Systemic lupus erythematosus
+∞
25.5
24
*
GD1AA
NOMESCO Finland
Thorax X-ray examination
4.4
24.5
141
618
G05.8*M32.1
ICD-10 Finland
Encephalitis in systemic lupus erythematosus
+∞
22.2
21
*
C08CA05
ATC
nifedipine; systemic
9.7
21.0
44
55
M35.1
ICD-10 Finland
Other overlap syndromes
121.3
21.0
22
*
D68.8
ICD-10 Finland
Other specified coagulation defects
50.9
19.6
23
5
G73.7*M32.1
ICD-10 Finland
Myopathy in systemic lupus erythematosus
+∞
19.0
18
*
TPH04
NOMESCO Finland
Cathetrisation of vein
4.3
18.9
86
285
R50.9
ICD-10 Finland
Fever, unspecified
5.2
18.7
65
164
L88
ICPC
Rheumatoid/seropositive arthritis
11.9
17.9
33
32
M05.8
ICD-10 Finland
Other seropositive rheumatoid arthritis
9.6
17.8
37
45
B01AA03
ATC
warfarin; systemic
4.9
17.4
64
170
ZX120
NOMESCO Finland
Intravenous
5.8
16.7
50
105
M05BA07
ATC
risedronic acid; oral
15.2
16.5
27
20
A02BC02
ATC
pantoprazole; systemic
3.7
16.2
179
1149
L04AA01
ATC
[U] ciclosporin; systemic
19.0
16.0
24
14
H02AB04
ATC
methylprednisolone; systemic
4.2
15.6
67
206
N02AX02
ATC
tramadol; systemic, rectal
3.0
14.0
125
660
UJD10
NOMESCO Finland
Esophagoscopy, gastroscopy and duodenoscopy
3.2
13.9
94
409
E000001
ATC
NA
3.4
13.7
79
305
A02BC03
ATC
lansoprazole; oral
3.1
13.4
95
426
J18.9
ICD-10 Finland
Pneumonia, unspecified
3.7
13.3
65
220
S01XA20
ATC
artificial tears and other indifferent preparations; ophthalmic
2.9
13.1
127
695
Z01.0
ICD-10 Finland
Examination of eyes and vision
3.8
13.0
62
206
Z01.8
ICD-10 Finland
Other specified special examinations
3.3
12.8
78
312
D07AB08
ATC
desonide; topical
4.3
12.7
50
139
A49.9
ICD-10 Finland
Bacterial infection, unspecified
5.3
12.7
40
88
ND2AA
NOMESCO Finland
Hand and fingers X-ray examination
4.8
12.7
44
108
J01MA12
ATC
levofloxacin; systemic
3.7
12.5
61
205
C03CA01
ATC
furosemide; systemic
3.2
12.5
78
318
E0000UV
ATC
NA
2.8
12.2
118
633
J05AB01
ATC
aciclovir; systemic
3.2
12.2
78
320
P01BA01
ATC
chloroquine; systemic
49.5
12.0
14
*
XX9XE
NOMESCO Finland
Other ultrasound examination
31.9
11.8
15
5
A07AA02
ATC
nystatin; oral
5.6
11.8
35
72
B01AB05
ATC
enoxaparin; parenteral
2.9
11.7
93
442
JN3AE
NOMESCO Finland
Abdominal ultrasound examination
3.8
11.5
52
164
L04AD01
ATC
ciclosporin; systemic
13.7
11.4
19
15
N02AJ06
ATC
codeine and paracetamol; systemic
2.7
11.1
106
557
FM1EE
NOMESCO Finland
Extensive structural and functional ultrasound examination of heart
3.2
10.2
62
241
XF400
NOMESCO Finland
ECG with 12 standard connections
3.4
10.1
54
192
J05AB11
ATC
valaciclovir; oral
3.5
9.9
49
165
D69.3
ICD-10 Finland
Idiopathic thrombocytopenic purpura
57.5
9.7
11
*
J01FA06
ATC
roxithromycin; oral
2.5
9.7
120
713
J99.1*M32.1
ICD-10 Finland
Respiratory disorders in systemic: lupus erythematosus
+∞
9.4
9
*
AA1AD
NOMESCO Finland
CT of head and brain
2.9
9.4
67
289
A02BC01
ATC
omeprazole; systemic
2.6
9.3
81
396
M05BB03
ATC
alendronic acid and colecalciferol; oral
10.7
9.2
17
17
O99.89
ICD-10 Finland
Other specified diseases and conditions complicating pregnancy, childbirth and the puerperium
16.5
9.2
14
9
NH3AA
NOMESCO Finland
Foot and toes X-ray examination
4.0
9.1
37
105
GD1UA
NOMESCO Finland
Thorax X-ray examination outside radiological department
3.5
9.1
45
151
J01FF01
ATC
clindamycin; systemic
2.6
9.1
85
428
J01MA02
ATC
ciprofloxacin; systemic
2.4
8.9
99
548
M05BA01
ATC
etidronic acid; systemic
52.1
8.7
10
*
R06.0
ICD-10 Finland
Dyspnoea
2.7
8.6
69
319
KA3AT
NOMESCO Finland
Biopsy of kidney with ultrasound guidance
21.0
8.6
12
6
N08.5
ICD-10 Finland
Glomerular disorders in systemic connective tissue disorders
+∞
8.4
8
*
FM1AE
NOMESCO Finland
Standard cardiac ultrasound examination
3.1
8.3
50
192
ND2DA
NOMESCO Finland
Bilateral hand X-ray examination
8.7
8.2
17
21
I15.1
ICD-10 Finland
Hypertension secondary to other renal disorders
34.7
8.1
10
*
EBA10
NOMESCO Finland
Surgical removal of tooth
3.6
8.0
37
118
DM1AA
NOMESCO Finland
Paranasal sinuses X-ray examination without contrast
5.7
7.9
22
42
J01MA14
ATC
moxifloxacin; systemic
3.7
7.9
34
102
H26.3
ICD-10 Finland
Drug-induced cataract
46.6
7.8
9
*
FN1AC
NOMESCO Finland
Angiography of heart and/or coronary arteries
2.9
7.7
50
201
N02AA59
ATC
codeine, combinations excl. psycholeptics; systemic
2.2
7.5
117
743
R2130
NOMESCO Finland
Counselling and guidance which enhance independent living
4.1
7.5
29
79
SAA03
NOMESCO Finland
Extended examination of mouth
2.2
7.5
109
672
M05BX04
ATC
denosumab; parenteral
4.7
7.3
24
56
H04.10
ICD-10 Finland
Dry eye syndrome
3.3
7.3
36
121
B02.9
ICD-10 Finland
Zoster without complication
4.5
7.3
25
61
C02CA01
ATC
prazosin; oral
31.1
7.2
9
*
Z01.5
ICD-10 Finland
Diagnostic skin and sensitization tests
3.3
7.2
36
122
GD1DD
NOMESCO Finland
High resolution CT examination of lungs
5.3
7.2
21
43
B01AB04
ATC
dalteparin; parenteral
5.3
7.2
21
43
R07.4
ICD-10 Finland
Chest pain, unspecified
2.4
7.1
68
342
Z50.1
ICD-10 Finland
Other physical therapy
4.5
7.1
24
58
N02BE01
ATC
paracetamol; systemic, rectal
3.0
7.0
205
1722
I63.9
ICD-10 Finland
Cerebral infarction, unspecified
3.9
7.0
28
79
GD1ED
NOMESCO Finland
Extensive high resolution CT examination of lungs
7.1
6.9
16
24
L04AA13
ATC
leflunomide; oral
8.7
6.9
14
17
AA1CG
NOMESCO Finland
Extensive MRI examination of brain with high intensity magnet
3.5
6.9
32
102
NA3AA
NOMESCO Finland
Lumbar spine X-ray examination without contrast
3.2
6.9
36
126
L99
ICPC
Musculoskeletal disease other
7.6
6.8
15
21
M80.4
ICD-10 Finland
Drug-induced osteoporosis with pathological fracture
41.3
6.8
8
*
R4120
NOMESCO Finland
Occupational therapy
3.8
6.7
27
77
R59.1
ICD-10 Finland
Generalized enlarged lymph nodes
12.8
6.7
11
9
L27.0
ICD-10 Finland
Generalized skin eruption due to drugs and medicaments
10.5
6.6
12
12
A02BA02
ATC
ranitidine; systemic
2.5
6.6
55
257
Y83
ICD-10 Finland
Surgical operation and other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure
3.7
6.5
28
84
XPX99
NOMESCO Finland
Other diagnostic examination of periferal vessel
4.1
6.5
24
63
D07AC01
ATC
betamethasone; topical
2.1
6.5
90
534
T81.4
ICD-10 Finland
Infection following a procedure, not elsewhere classified
3.1
6.5
36
130
KH1AE
NOMESCO Finland
Urinary tract ultrasound examination
4.9
6.5
20
44
SPAT1148
SPAT
Treatment of chronic ulcer or burn
3.0
6.4
37
139
Z96.1
ICD-10 Finland
Presence of intraocular lens
3.3
6.4
32
109
A01AC01
ATC
triamcinolone; local oral
11.5
6.4
11
10
D69.6
ICD-10 Finland
Thrombocytopenia, unspecified
11.5
6.4
11
10
318
Kela drug reimbursment
Teriparatide
18.7
6.3
9
5
SPAT1325
SPAT
Vaccination
2.2
6.3
81
465
N05.8
ICD-10 Finland
Unspecified nephritic syndrome, other
+∞
6.3
6
*
N16.4*M32.1
ICD-10 Finland
Renal tubulo-interstitial disorders in systemic lupus erythematosus
+∞
6.3
6
*
7108X
ICD-9 Finland
Diffuse diseases of connective tissue, Other specified diffuse diseases of connective tissue
+∞
6.3
6
*
QX2XE
NOMESCO Finland
Ultrsound examination of soft tissue not elsewhere classified
6.1
6.3
16
28
N32.9
ICD-10 Finland
Bladder disorder, unspecified
27.5
6.3
8
*
1XC02
NOMESCO Finland
NA
27.5
6.3
8
*
QDB10
NOMESCO Finland
Major dressing of wound of skin of lower limb
4.7
6.2
20
46
J01EE01
ATC
sulfamethoxazole and trimethoprim; systemic
3.9
6.2
24
66
UGC12
NOMESCO Finland
Flexible bronchoscopy
4.1
6.2
23
61
I69.3
ICD-10 Finland
Sequelae of cerebral infarction
4.4
6.2
21
51
C09AA02
ATC
enalapril; systemic
2.6
6.2
47
206
205
Kela drug reimbursment
Chronic hypertension
2.3
6.2
61
310
Z50.8
ICD-10 Finland
Care involving use of other rehabilitation procedures
3.6
6.2
27
83
R5110
NOMESCO Finland
Evaluation of the need for aids, the testing, fitting and choice of the aid, instruction in use and delivery of it
3.1
6.1
34
123
J02AC01
ATC
fluconazole; systemic
2.0
6.1
127
882
X59
ICD-10 Finland
Exposure to unspecified factor
2.5
6.1
52
245
A02BC05
ATC
esomeprazole; systemic
2.0
6.1
105
678
N03AX16
ATC
pregabalin; oral
2.2
6.0
66
351
WZB00
NOMESCO Finland
Telephone receipt or other advice
2.1
6.0
79
453
S97
ICPC
Chronic ulcer skin
4.7
6.0
19
43
LabWAS
↥OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
unit
cases
controls
-log10(p)
N cases
N controls
(3002434) Lupus erythematosus deoxynucleoproteins IgG Ab [Units/volume] in Serum by Immunoassay
113
84
24.62
130.49
8.7
2.0
—
—
—
0
0
(3016921) Smith extractable nuclear Ab [Units/volume] in Serum
77
67
16.48
78.99
1.8
1.3
u/ml
21.9
2.9
—
22
10
(3006999) Ribonucleoprotein extractable nuclear Ab [Units/volume] in Serum
76
68
15.92
76.56
1.8
1.3
u/ml
12.1
9.0
0.18
28
15
(3027450) Sjogrens syndrome-B extractable nuclear Ab [Units/volume] in Serum
77
72
15.30
75.45
1.8
1.3
u/ml
32.6
1.2
—
14
5
(3025245) SCL-70 extractable nuclear Ab [Units/volume] in Serum by Immunoassay
64
53
16.13
67.02
1.7
1.3
u/ml
2.2
1.0
—
8
5
(3037522) Nuclear Ab [Titer] in Serum
132
306
8.40
61.83
2.8
1.4
titre
741.7
551.1
0.76
92
72
(3015171) Extractable nuclear Ab [Units/volume] in Serum
72
86
11.55
59.07
1.9
1.3
u/ml
0.9
2.0
—
7
5
(3023939) Sjogrens syndrome-A extractable nuclear Ab [Units/volume] in Serum
57
60
12.16
50.72
1.7
1.3
u/ml
52.3
34.5
—
20
9
(42870588) Differential panel, method unspecified - Blood
173
641
7.15
46.62
15.2
5.7
—
—
—
0
0
(3044355) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum or Plasma by Immunoassay
44
35
15.18
46.49
1.7
1.2
u/ml
7.5
1.5
1.23
30
11
(4268621)
37
24
18.06
43.50
2.8
2.0
—
—
—
0
0
(3009041) Cardiolipin IgG Ab [Units/volume] in Serum by Immunoassay
43
39
13.23
41.86
1.8
1.1
u/ml
7.7
5.3
0.28
26
14
(40759836) Histone Ab [Presence] in Serum by Immunoblot
34
23
17.07
39.01
1.6
1.2
—
—
—
0
0
(40759812) SCL-70 extractable nuclear Ab [Presence] in Serum by Immunoblot
34
23
17.07
39.01
1.6
1.2
—
—
—
0
0
(40759849) Smith extractable nuclear Ab [Presence] in Serum by Immunoblot
34
23
17.07
39.01
1.6
1.2
—
—
—
0
0
(40759842) Ribonucleoprotein extractable nuclear Ab [Presence] in Serum by Immunoblot
34
24
16.35
38.13
1.6
1.2
—
—
—
0
0
(40759844) Sjogrens syndrome-B extractable nuclear Ab [Presence] in Serum by Immunoblot
34
24
16.35
38.13
1.6
1.2
—
—
—
0
0
(40759843) Sjogrens syndrome-A extractable nuclear Ab [Presence] in Serum by Immunoblot
34
24
16.35
38.13
1.6
1.2
—
—
—
0
0
(3006315) Basophils [#/volume] in Blood
205
1000
8.38
37.51
17.8
5.5
e9/l
0.0
0.0
0.34
196
874
(3001604) Monocytes [#/volume] in Blood
204
997
8.14
37.04
17.8
5.5
e9/l
0.6
0.5
1.36
196
871
(3019198) Lymphocytes [#/volume] in Blood
205
1025
8.03
35.68
17.8
5.5
e9/l
1.6
1.9
2.26
199
918
(3013115) Eosinophils [#/volume] in Blood
206
1039
8.12
35.37
18.3
5.7
e9/l
0.2
0.2
1.79
200
923
(3002179) Metamyelocytes/100 leukocytes in Blood
65
143
5.87
29.67
6.1
3.9
%
0.2
0.8
1.32
19
32
(3013650) Neutrophils [#/volume] in Blood by Automated count
208
1176
6.93
27.89
21.1
9.1
e9/l
3.6
3.9
1.98
200
1038
(3021440) Promyelocytes/100 leukocytes in Blood
62
145
5.42
26.23
6.8
4.0
%
0.0
0.3
1.98
24
38
(3017181) Myelocytes/100 leukocytes in Blood
65
160
5.21
25.91
6.7
3.8
%
0.6
1.2
1.27
24
46
(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma
172
872
4.47
25.62
3.6
2.3
nmol/l
80.1
77.6
0.57
166
787
(3022250) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction
68
186
4.71
23.69
3.9
4.6
u/l
257.8
245.2
0.39
68
179
(3026782) Osmolality of Urine
99
359
4.00
23.57
6.2
2.5
mosm/kgh2o
499.1
531.6
0.79
89
308
(3025159) Blasts/100 leukocytes in Blood
58
140
5.15
23.50
6.9
4.0
%
0.0
0.2
0.49
19
33
(3004789) Transferrin [Mass/volume] in Serum or Plasma
80
250
4.31
23.42
4.2
2.2
g/l
2.2
2.5
3.85
80
230
(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma
175
939
4.23
23.05
12.7
6.0
mmol/l
1.2
1.2
0.22
159
793
(3002582) Erythrocytes [#/volume] in Urine
128
561
3.76
22.85
7.1
2.9
e6/l
19.1
153.3
0.61
106
428
(3000850) Epithelial cells [#/volume] in Urine
102
390
3.82
22.27
4.6
2.4
e6/l
3.6
7.5
1.15
91
350
(40763571) Iron/Transferrin [Ratio] in Serum or Plasma
75
234
4.21
21.85
4.3
2.3
%
21.7
22.6
0.22
67
200
(3029287) Urinalysis microscopic panel [#/volume] - Urine by Automated count
140
666
3.66
21.71
7.9
2.9
—
—
—
0
0
(3030467) Casts [#/volume] in Urine by Automated count
119
512
3.64
21.57
7.1
2.7
e6/l
0.1
0.4
1.65
97
378
(3018095) Leukocytes [#/volume] in Urine
141
676
3.65
21.56
8.9
3.5
e6/l
68.1
76.2
0.07
111
464
(3023368) Bacteria identified in Blood by Culture
109
444
3.67
21.49
6.1
3.8
—
—
—
0
0
(36304419) Bacteria [Presence] in Urine
118
515
3.55
20.73
6.0
2.7
—
—
—
0
0
(3022948) Iron [Moles/volume] in Serum or Plasma
80
281
3.78
19.45
4.1
2.2
umol/l
11.5
14.1
2.38
80
257
(3027945) Reticulocytes/100 erythrocytes in Blood
63
189
4.17
19.14
4.2
3.1
%
1.6
1.8
0.57
63
178
(40762119) U1 small nuclear ribonucleoprotein 70kD Ab [Units/volume] in Serum
22
23
10.43
19.07
1.6
1.1
—
—
—
0
0
(3021601) Nitrite [Presence] in Urine by Test strip
175
1018
3.69
18.65
11.3
4.6
estimate
0.0
0.0
0.00
39
193
(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay
25
32
8.61
18.64
4.5
5.8
u/ml
0.3
0.4
0.57
14
22
(3015736) pH of Urine
148
782
3.34
18.38
6.5
3.2
—
—
—
0
0
(3035350) Ketones [Presence] in Urine by Test strip
173
1007
3.60
18.24
7.7
3.4
estimate
0.0
0.0
0.00
38
198
(3009261) Glucose [Presence] in Urine by Test strip
174
1029
3.54
17.61
7.8
3.4
estimate
0.0
0.0
0.00
37
186
(3012544) pH of Venous blood
54
155
4.21
17.30
6.4
4.1
—
—
—
0
0
(3028026) IgM [Mass/volume] in Serum or Plasma
50
136
4.38
17.19
1.7
1.7
g/l
1.2
1.4
0.36
45
126
(3002032) Base excess in Venous blood by calculation
53
152
4.20
16.98
6.3
4.2
mmol/l
1.9
2.1
0.12
48
122
(3011412) CD3 cells [#/volume] in Blood
19
19
10.78
16.92
1.8
1.8
e9/l
1.0
1.2
—
10
6
(3010503) CD19 cells [#/volume] in Blood
15
10
15.94
16.90
1.9
2.4
e9/l
0.0
0.2
—
15
10
(3037467) Urinalysis macro (dipstick) panel - Urine
208
1400
4.74
16.85
11.9
4.1
—
—
—
0
0
(46235128) Lupus anticoagulant aPTT and dRVVT screening panel W Reflex
17
15
12.12
16.38
1.4
1.2
—
—
—
0
0
(3024561) Albumin [Mass/volume] in Serum or Plasma
147
813
3.10
16.15
8.2
3.9
g/l
34.4
36.2
3.82
142
766
(3004616) Nuclear Ab [Presence] in Serum
23
32
7.85
15.97
1.9
1.3
—
—
—
0
0
(3023520) Reticulocytes [#/volume] in Blood
48
135
4.20
15.72
3.3
3.0
e9/l
64.1
72.4
0.87
34
107
(3004588) Protein electrophoresis panel - Serum or Plasma
41
107
4.42
14.77
1.8
2.2
—
—
—
0
0
(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma
23
35
7.16
14.75
1.3
1.5
—
—
—
0
0
(21493690) Lymphocyte T-cell and B-cell and Natural killer subsets panel - Blood
14
11
13.46
14.37
1.6
1.5
—
—
—
0
0
(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
31
67
5.17
13.98
2.0
1.6
—
—
—
0
0
(3042936) Bacteria identified in Isolate by Culture
70
274
3.20
13.83
2.9
2.0
—
—
—
0
0
(3037756) Immunofixation for Serum or Plasma
22
35
6.82
13.53
1.2
2.0
—
—
—
0
0
(3046294) Neutrophil cytoplasmic Ab.classic [Titer] in Serum
13
10
13.69
13.47
1.5
1.3
—
—
—
0
0
(3026008) Bacteria identified in Urine by Culture
115
599
2.77
13.41
3.2
2.8
—
—
—
0
0
(3018418) pH of Serum or Plasma
114
595
2.75
13.19
8.3
3.8
ph
7.4
7.4
2.29
22
111
(3011397) Hemoglobin [Presence] in Urine by Test strip
94
445
2.83
13.12
6.0
3.5
—
—
—
0
0
(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count
73
301
3.05
13.12
6.4
2.5
e6/l
0.6
1.0
1.59
45
161
(3034426) Prothrombin time (PT)
13
11
12.44
12.74
1.5
1.2
—
—
—
0
0
(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma
93
446
2.78
12.57
4.2
2.1
mg/l
2.9
3.2
0.48
88
379
(3021589) Normoblasts [#/volume] in Blood
149
908
2.70
12.39
19.8
8.4
e9/l
0.0
0.0
0.06
134
738
(3015635) Cytomegalovirus IgM Ab [Units/volume] in Serum or Plasma
21
35
6.48
12.35
1.3
1.4
—
—
—
0
0
(36304997) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ and CD8+ T-cells [Units/volume] in Blood
27
58
5.12
12.22
1.8
1.7
iu/ml
0.0
0.0
—
7
6
(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count
68
281
2.98
12.07
6.9
2.7
e6/l
1.9
3.4
0.95
41
141
(3013707) Erythrocyte sedimentation rate by Westergren method
210
1551
3.92
11.99
14.2
4.0
mm/h
15.6
10.9
5.31
204
1434
(3032080) INR in Blood by Coagulation assay
126
716
2.61
11.96
15.3
6.7
inr
1.5
1.1
1.81
32
216
(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells
23
44
5.68
11.79
1.7
2.0
—
—
—
0
0
(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection
65
268
2.96
11.53
2.6
1.8
—
—
—
0
0
(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection
51
184
3.25
11.37
2.6
1.7
—
—
—
0
0
(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection
50
186
3.13
10.55
2.7
1.7
—
—
—
0
0
(3007853) Bacteria identified in Skin by Aerobe culture
54
211
3.01
10.47
2.5
1.5
—
—
—
0
0
(3020682) Albumin/Creatinine [Ratio] in Urine
102
554
2.47
10.28
7.4
3.7
mg/mmol
22.0
9.6
1.01
80
317
(40759883) Oligoclonal Bands IgG [Presence] in Cerebral spinal fluid by Isoelectric focusing
11
10
11.48
10.23
1.2
1.0
—
—
—
0
0
(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma
90
467
2.49
9.96
2.9
1.8
mg/l
1.3
0.9
0.77
77
357
(40760892) CBC W Ordered Manual Differential panel - Blood
93
500
2.41
9.43
12.2
4.4
—
—
—
0
0
(3009508) Creatinine [Moles/volume] in Urine
102
572
2.37
9.39
5.3
2.8
mmol/l
6.2
7.3
2.40
96
476
(3021788) Differential panel - Synovial fluid
16
27
6.28
9.25
1.7
1.6
—
—
—
0
0
(3000991) Gas panel - Venous blood
39
135
3.26
9.22
15.0
6.3
—
—
—
0
0
(3013293) Extractable nuclear Ab [Presence] in Serum
12
5
25.14
9.00
1.7
1.8
—
—
—
0
0
(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection
37
128
3.24
8.74
1.8
1.5
—
—
—
0
0
(40758897) Direct antiglobulin test.IgG specific reagent [Presence] on Red Blood Cells
10
10
10.39
8.70
1.6
2.5
—
—
—
0
0
(40758895) Direct antiglobulin test.complement C3d specific reagent [Presence] on Red Blood Cells
10
10
10.39
8.70
1.6
2.5
—
—
—
0
0
(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma
90
492
2.33
8.65
3.5
3.2
ng/l
1405.5
866.6
0.74
82
413
(3012516) Albumin [Mass/volume] in Urine
94
526
2.30
8.53
5.4
3.0
mg/l
121.0
322.6
0.53
70
315
(3035999) Lactate [Moles/volume] in Cerebral spinal fluid
12
16
7.84
8.49
1.2
1.3
mmol/l
2.1
2.0
0.10
12
16
(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum
21
50
4.51
8.38
1.5
1.2
—
—
—
0
0
(3050238) Crystals [Presence] in Synovial fluid by Light microscopy
19
42
4.83
8.28
1.7
1.3
—
—
—
0
0
(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection
20
47
4.55
8.11
2.0
2.2
—
—
—
0
0
(40768446) Kidney Pathology biopsy report
11
5
22.95
8.09
1.5
2.0
—
—
—
0
0
(40768443) Skin Pathology biopsy report
28
85
3.60
8.08
1.3
1.2
—
—
—
0
0
(3032035) Polymorphonuclear cells/100 leukocytes in Blood
19
44
4.60
7.84
5.5
3.7
%
62.2
62.2
0.01
19
44
(4027681)
10
12
8.65
7.63
1.2
1.3
—
—
—
0
0
(3052851) Hemolysis interference index of Serum or Plasma
21
54
4.17
7.61
2.8
2.6
—
—
—
0
0
(46236098) ABO and Rh group [Type] in Blood by Confirmatory method
81
445
2.24
7.52
3.0
2.2
—
—
—
0
0
(3010380) Borrelia burgdorferi IgG Ab [Units/volume] in Cerebral spinal fluid
11
16
7.16
7.21
1.2
1.1
—
—
—
0
0
(3044290) Cell count panel - Cerebral spinal fluid
18
43
4.45
7.15
1.2
1.6
—
—
—
0
0
(40758558) Short blood count panel - Blood
91
534
2.14
7.10
13.1
6.8
—
—
—
0
0
(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing
16
35
4.83
7.04
1.8
1.5
—
—
—
0
0
(3007164) IgA [Mass/volume] in Serum or Plasma
81
458
2.16
6.92
1.8
1.4
g/l
2.4
2.2
0.97
58
286
(3012220) Varicella zoster virus IgM Ab [Presence] in Serum by Immunoassay
10
14
7.41
6.75
1.1
1.2
—
—
—
0
0
(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma
64
332
2.27
6.74
6.7
3.4
ng/l
374.2
134.8
0.91
51
237
(3017143) Hepatitis C virus Ab [Presence] in Serum
49
226
2.47
6.72
1.7
1.5
—
—
—
0
0
(40768797) Stomach Pathology biopsy report
57
283
2.33
6.64
1.3
1.2
—
—
—
0
0
(3007844) Epstein Barr virus capsid IgM Ab [Units/volume] in Serum by Immunoassay
16
37
4.56
6.60
1.3
1.5
—
—
—
0
0
(3001122) Ferritin [Mass/volume] in Serum or Plasma
135
936
2.02
6.53
5.1
2.7
ug/l
182.1
90.6
1.75
130
876
(3005702) Mycobacterium sp identified in Specimen by Organism specific culture
16
38
4.44
6.39
1.1
1.4
—
—
—
0
0
(3048689) Calprotectin [Mass/mass] in Stool
54
266
2.33
6.39
3.8
2.0
ug/g
143.8
98.6
0.71
49
209
(43054903) Holo-transcobalamin II [Moles/volume] in Serum
116
767
2.00
6.38
2.2
1.9
pmol/l
97.3
99.8
0.22
58
370
(3021879) Hepatitis B virus core Ab [Presence] in Serum
35
140
2.76
6.38
1.5
1.4
—
—
—
0
0
(3019284) Hepatitis B virus surface Ag [Presence] in Serum
58
295
2.28
6.37
1.7
1.6
—
—
—
0
0
(3000093) Morphology [Interpretation] in Blood Narrative
10
15
6.91
6.36
1.2
1.3
—
—
—
0
0
(44790048)
10
15
6.91
6.36
1.5
1.6
—
—
—
0
0
(44790049)
10
15
6.91
6.36
1.5
1.6
—
—
—
0
0
(44806118)
10
15
6.91
6.36
1.5
1.6
—
—
—
0
0
(44790047)
10
15
6.91
6.36
1.5
1.6
—
—
—
0
0
(3007566) Smooth muscle Ab [Titer] in Serum
20
58
3.67
6.16
1.3
1.2
—
75.0
—
0
6
(3048929) Epstein Barr virus Ab [Presence] in Serum
20
58
3.67
6.16
1.4
1.5
—
—
—
0
0
(3030905) Polymorphonuclear cells [#/volume] in Blood
17
44
4.08
6.10
5.2
3.2
e9/l
3.7
4.9
1.71
17
44
(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma
147
1072
1.96
5.92
7.1
5.6
umol/l
9.8
10.1
0.14
142
1006
(3044640) Blood type and Crossmatch panel - Blood
97
616
1.97
5.87
3.2
2.2
—
—
—
0
0
(3014576) Chloride [Moles/volume] in Serum or Plasma
44
205
2.41
5.87
10.3
5.1
mmol/l
105.6
103.6
2.33
44
197
(46235355) HIV 1 and 2 tests - Meaningful Use set
63
342
2.14
5.86
1.9
1.9
—
—
—
0
0
(43055089) Myosin Ab [Presence] in Serum or Plasma by Immunoblot
10
9
11.53
5.85
1.2
1.0
—
—
—
0
0
(3022217) INR in Platelet poor plasma by Coagulation assay
45
213
2.37
5.80
51.5
18.6
inr
1.5
1.3
—
7
31
(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection
17
46
3.90
5.75
1.4
1.6
—
—
—
0
0
(3005895) Myoglobin [Mass/volume] in Serum or Plasma
17
47
3.82
5.59
1.8
1.7
ug/l
80.9
225.6
1.79
17
42
(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum
13
29
4.68
5.58
1.2
1.2
—
—
—
0
0
(3011166) Borrelia burgdorferi Ab [Presence] in Cerebral spinal fluid
10
18
5.75
5.37
1.1
1.0
—
—
—
0
0
(3014973) Borrelia burgdorferi IgM Ab [Units/volume] in Cerebral spinal fluid
10
18
5.75
5.37
1.2
1.1
—
—
—
0
0
(3016018) Differential panel - Cerebral spinal fluid
10
19
5.45
5.08
1.2
1.8
—
—
—
0
0
(3026389) Candida sp identified in Specimen by Organism specific culture
11
23
4.97
5.06
1.4
1.5
—
—
—
0
0
(3024928) Oxygen saturation in Venous blood
14
36
4.07
5.06
9.8
2.3
—
—
—
0
0
(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection
25
95
2.82
5.00
2.1
1.6
—
—
—
0
0
(36305247) Microscopic observation [Identifier] in Isolate by Gram stain
16
46
3.66
4.99
1.6
1.5
—
—
—
0
0
(3008037) Lactate [Moles/volume] in Venous blood
13
32
4.24
4.96
2.8
2.9
mmol/l
1.0
1.3
1.52
13
32
(3019309) Folate [Moles/volume] in Red Blood Cells
58
324
2.04
4.93
1.6
1.7
nmol/l
1163.5
1274.1
0.49
49
244
(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma
104
707
1.83
4.91
4.2
3.3
ng/l
32.0
29.8
0.08
77
427
(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip
114
798
1.82
4.89
8.4
3.5
—
—
—
0
0
(3017732) Neutrophils [#/volume] in Blood
32
141
2.47
4.80
2.9
2.3
e9/l
3.3
3.9
0.85
25
119
(3037121) Protein [Mass/volume] in Urine
19
63
3.19
4.79
4.5
2.8
g/l
0.2
0.2
—
10
19
(3001079) Blood group antibody screen [Presence] in Serum or Plasma
130
952
1.80
4.75
5.5
3.8
—
—
—
0
0
(3027273) Bicarbonate [Moles/volume] in Venous blood
23
86
2.85
4.74
2.2
3.7
mmol/l
25.9
24.8
0.83
23
86
(3003396) Base excess in Arterial blood by calculation
39
191
2.25
4.62
9.9
5.6
mmol/l
-0.2
1.3
1.04
33
151
(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection
11
25
4.56
4.61
1.3
1.5
—
—
—
0
0
(3001964) Herpes simplex virus Ag [Presence] in Specimen
7
5
14.36
4.60
1.1
1.6
—
—
—
0
0
(42868414) European tick borne encephalitis virus IgM Ab [Presence] in Serum by Immunoassay
7
5
14.36
4.60
1.0
1.4
—
—
—
0
0
(3008757) Leukocyte morphology finding [Identifier] in Blood
10
21
4.93
4.57
3.7
4.4
—
—
—
0
0
(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection
15
44
3.57
4.54
1.4
1.7
—
—
—
0
0
(3021960) Folate [Moles/volume] in Serum or Plasma
71
437
1.89
4.53
1.8
1.4
nmol/l
21.2
21.8
0.13
64
366
(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection
12
30
4.16
4.49
1.3
1.5
—
—
—
0
0
(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay
17
55
3.25
4.46
1.6
1.3
—
—
—
0
0
(21492711) Cytomegalovirus IgG Ab avidity [Presence] in Serum or Plasma by Immunoassay
9
12
7.74
4.39
1.2
1.3
—
—
—
0
0
(3022313) Gas panel - Capillary blood
21
78
2.86
4.38
6.2
3.8
—
—
—
0
0
(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection
10
22
4.70
4.34
1.1
1.6
—
—
—
0
0
(3041096) Erythrocytes [Presence] in Urine by Automated
88
586
1.79
4.34
8.2
3.0
—
—
—
0
0
(3019225) pH of Specimen
35
171
2.23
4.17
6.1
4.5
—
—
—
0
0
(3038515) Glucose [Moles/volume] in Venous blood
12
32
3.90
4.14
2.8
2.9
mmol/l
5.8
6.8
1.15
12
32
(42868544) Hantavirus puumala IgM Ab [Presence] in Serum or Plasma by Immunofluorescence
10
23
4.49
4.13
1.6
1.2
—
—
—
0
0
(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay
13
37
3.66
4.11
1.6
1.2
—
—
—
0
0
(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay
13
37
3.66
4.11
1.6
1.2
—
—
—
0
0
(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay
17
58
3.08
4.10
1.4
1.1
—
—
—
0
0
(3000494) Fungus identified in Specimen by Culture
47
260
2.01
4.07
1.7
1.3
—
—
—
0
0
(3011436) Histone Ab [Units/volume] in Serum
7
7
10.25
4.03
1.4
1.3
—
—
—
0
0
(40762485) Glomerular basement membrane Ab [Units/volume] in Serum by Immunoassay
9
14
6.63
4.02
1.0
1.1
—
—
—
0
0
(3046870) Tissue transglutaminase IgG Ab [Units/volume] in Serum
21
83
2.68
3.92
1.0
1.0
—
—
—
0
0
(3021197) Magnesium Ionized [Moles/volume] in Serum or Plasma
8
11
7.48
3.89
1.5
1.6
—
—
—
0
0
(40760888) Immunoglobulin light chains.free panel - Serum
11
29
3.93
3.85
1.4
3.5
—
—
—
0
0
(3019230) Fractional oxyhemoglobin in Venous blood
11
29
3.93
3.85
11.9
1.8
%
68.9
58.7
0.95
11
29
(36660697) Celiac disease serology panel - Serum
34
170
2.17
3.83
1.2
1.2
—
—
—
0
0
(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
7
8
8.97
3.80
1.3
1.3
—
—
—
0
0
(40757349) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Blood
7
8
8.97
3.80
1.9
2.3
—
—
—
0
0
(3015377) Calcium [Moles/volume] in Serum or Plasma
96
680
1.69
3.69
3.5
3.1
mmol/l
2.3
2.4
1.09
89
597
(3029937) Albumin [Presence] in Urine by Test strip
81
550
1.72
3.62
7.8
3.8
estimate
0.0
0.0
0.00
39
194
(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum
76
507
1.73
3.62
1.4
1.3
u/ml
0.6
1.7
0.87
16
161
(3013721) Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma
96
683
1.68
3.61
4.2
3.0
u/l
28.9
29.2
0.04
89
651
(3009595) Pneumocystis jiroveci DNA [Presence] in Specimen by NAA with probe detection
9
17
5.45
3.54
2.3
1.3
—
—
—
0
0
(3016724) Homocysteine [Moles/volume] in Serum or Plasma
8
13
6.32
3.53
1.5
1.8
umol/l
13.6
12.5
—
8
13
(3033386) Bacteria [Presence] in Cerebral spinal fluid by Light microscopy
6
7
8.75
3.28
1.2
1.3
—
—
—
0
0
(43055554) Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation
23
104
2.34
3.28
6.5
4.0
mmol/l
0.7
1.7
0.33
18
83
(3019150) Specific gravity of Urine by Refractometry
67
444
1.71
3.23
6.9
3.6
kg/l
1.0
1.0
3.51
11
55
(3004529) Oxygen [Partial pressure] adjusted to patient's actual temperature in Venous blood
19
79
2.53
3.23
3.7
3.6
%
39.1
51.1
1.08
19
79
(3014148) Varicella zoster virus Ab [Titer] in Serum
8
15
5.48
3.22
1.1
1.3
—
—
—
0
0
(3045414) Leukocytes [Presence] in Urine
21
92
2.41
3.20
2.5
1.7
—
—
—
0
0
(3042596) Human coronavirus RNA [Presence] in Specimen by NAA with probe detection
9
20
4.63
3.14
1.1
1.3
—
—
—
0
0
(3013512) EKG study
77
534
1.65
3.12
4.4
3.5
—
—
—
0
0
(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum
62
406
1.71
3.11
1.4
1.3
u/ml
12.1
8.8
0.17
27
166
(40762366) Oxygen capacity [Volume Fraction] in Arterial blood
20
87
2.42
3.10
13.3
6.1
—
—
—
0
0
(3044941) Cell count panel - Synovial fluid
10
29
3.56
3.08
2.6
1.4
—
—
—
0
0
(3016914) Bacteria identified in Cerebral spinal fluid by Culture
8
16
5.13
3.07
1.4
1.3
—
—
—
0
0
(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection
21
94
2.35
3.06
2.0
1.4
—
—
—
0
0
(3016293) Bicarbonate [Moles/volume] in Serum or Plasma
22
101
2.30
3.04
7.3
5.6
mmol/l
23.7
25.0
0.73
22
101
(3013727) Leukocytes other/100 leukocytes in Blood
5
5
10.17
2.99
1.2
1.2
%
63.0
66.9
—
5
5
(3019060) Gas panel - Arterial blood
23
110
2.21
2.90
3.7
4.5
—
—
—
0
0
(3011363) Streptococcus pneumoniae Ag [Presence] in Urine
6
9
6.80
2.88
1.0
1.2
—
—
—
0
0
(3007847) Interleukin 2 Receptor Soluble [Units/volume] in Serum or Plasma
6
9
6.80
2.88
2.3
2.3
u/ml
627.0
778.7
—
6
9
(3004490) Bicarbonate [Moles/volume] standard in Capillary blood
17
71
2.50
2.87
6.9
4.0
mmol/l
24.2
24.9
0.37
17
71
(3010517) Carboxyhemoglobin/Hemoglobin.total in Venous blood
20
91
2.31
2.82
7.9
2.8
%
1.5
1.2
0.41
20
91
(3023410) Appearance of Cerebral spinal fluid
9
23
4.02
2.80
1.2
1.8
—
—
—
0
0
(3024139) IgG subclass 3 [Mass/volume] in Serum
9
24
3.85
2.70
1.4
1.3
g/l
0.7
0.4
—
9
19
(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection
9
24
3.85
2.70
1.2
1.4
—
—
—
0
0
(4062490)
9
24
3.85
2.70
1.4
1.3
—
—
—
0
0
(3028192) IgG subclass 2 [Mass/volume] in Serum
9
24
3.85
2.70
1.4
1.3
g/l
3.4
2.8
—
9
19
(3027135) IgG subclass 1 [Mass/volume] in Serum
9
24
3.85
2.70
1.4
1.3
g/l
7.8
6.6
—
9
19
(3025130) Human papilloma virus identified in Specimen
10
32
3.22
2.68
2.5
2.1
—
—
—
0
0
(3002173) Hemoglobin [Mass/volume] in Arterial blood
30
165
1.94
2.64
10.8
5.7
g/l
112.6
121.0
1.31
30
160
(3027544) Mycobacterium sp identified in Sputum by Organism specific culture
8
20
4.10
2.59
2.9
3.9
—
—
—
0
0
(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture
33
189
1.87
2.58
4.1
3.6
—
—
—
0
0
(3002222) Hepatitis E virus IgM Ab [Presence] in Serum
5
7
7.26
2.56
1.0
1.1
—
—
—
0
0
(3029023) Hepatitis E virus IgG Ab [Presence] in Serum by Immunoassay
5
7
7.26
2.56
1.0
1.1
—
—
—
0
0
(3045424) Erythrocytes [Presence] in Urine
11
39
2.91
2.51
1.6
1.6
—
—
—
0
0
(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection
10
34
3.03
2.44
1.2
1.7
—
—
—
0
0
(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection
15
64
2.43
2.44
2.1
1.9
—
—
—
0
0
(3020460) C reactive protein [Mass/volume] in Serum or Plasma
222
2054
2.14
2.43
36.7
12.2
mg/l
17.2
20.6
1.18
208
1572
(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection
13
52
2.59
2.40
1.8
1.3
—
—
—
0
0
(3012202) Varicella zoster virus DNA [Presence] in Specimen by NAA with probe detection
5
8
6.35
2.38
1.0
1.1
—
—
—
0
0
(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma
60
417
1.59
2.35
1.4
1.3
iu/ml
28.5
28.0
0.02
19
146
(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection
8
23
3.56
2.29
1.1
1.5
—
—
—
0
0
(3021952) Alkaline phosphatase isoenzymes [Enzymatic activity/volume] in Serum or Plasma by Heat stability
9
29
3.18
2.25
1.2
1.3
—
—
—
0
0
(3049714) Procollagen type I.N-terminal propeptide [Mass/volume] in Serum
5
9
5.65
2.22
2.6
1.9
ug/l
38.4
70.2
—
5
9
(3006922) Hepatitis E virus Ab [Presence] in Serum
5
9
5.65
2.22
1.0
1.2
—
—
—
0
0
(3041145) Herpes simplex virus IgM Ab [Presence] in Serum by Immunoassay
5
9
5.65
2.22
1.2
1.4
—
—
—
0
0
(3003265) Liver kidney microsomal Ab [Titer] in Serum by Immunofluorescence
7
19
3.76
2.16
1.6
1.5
—
—
—
0
0
(3001467) Alkaline phosphatase.bone [Enzymatic activity/volume] in Serum or Plasma
7
19
3.76
2.16
1.3
1.3
u/l
38.3
53.9
—
7
11
(3023419) Bacteria identified in Sputum by Culture
7
19
3.76
2.16
3.1
2.1
—
—
—
0
0
(3000570) Elastase.pancreatic [Mass/mass] in Stool
15
68
2.29
2.16
1.1
1.4
ug/g
353.8
317.5
—
9
40
(1175715) Chlamydophila pneumoniae IgM Ab [Presence] in Serum by Immunoassay
10
37
2.78
2.13
1.5
1.1
—
—
—
0
0
(46236952) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)
29
171
1.79
2.08
2.9
2.5
ml/min/173m2
52.2
70.8
1.81
15
66
(40768804) Tissue Pathology biopsy report
110
889
1.44
2.04
2.4
2.0
—
—
—
0
0
(3042111) Morphology [Interpretation] in Bone marrow Narrative
8
26
3.15
2.03
1.3
1.3
—
—
—
0
0
(3000330) Specific gravity of Urine by Test strip
17
84
2.10
2.01
14.2
2.8
—
—
—
0
0
(3027529) Toxoplasma gondii IgM Ab [Units/volume] in Serum
7
21
3.40
1.98
1.1
1.3
—
—
—
0
0
(40761535) Cells panel - Urine sediment
26
151
1.81
1.96
6.2
3.2
—
—
—
0
0
(40766800) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ T-cells [Units/volume] corrected for background in Blood
8
27
3.03
1.95
1.5
1.1
—
—
—
0
0
(3010838) Calcium [Moles/time] in 24 hour Urine
5
11
4.62
1.95
1.0
1.5
—
—
—
0
0
(3052649) Adenosine deaminase [Enzymatic activity/volume] in Serum or Plasma
5
11
4.62
1.95
1.0
1.6
u/l
15.0
12.2
—
5
11
(3035947) Staphylolysin Ab [Units/volume] in Serum
5
11
4.62
1.95
1.0
1.2
—
—
—
0
0
(3012447) Hantavirus puumala IgG Ab [Titer] in Serum
6
16
3.82
1.94
1.5
1.2
—
—
—
0
0
(4035726)
31
191
1.72
1.93
1.4
1.4
—
—
—
0
0
(3014959) Toxoplasma gondii IgG Ab [Units/volume] in Serum
7
22
3.25
1.89
2.3
2.5
—
—
—
0
0
(3047007) Chlamydophila sp Ab [Presence] in Serum
9
34
2.71
1.88
1.6
1.1
—
—
—
0
0
(1761482) Bacteria [#/volume] in Urine by Culture
10
41
2.50
1.78
10.4
3.9
—
—
—
0
0
(3023150) Myeloperoxidase Ab [Units/volume] in Serum
9
36
2.56
1.76
1.1
1.2
—
—
—
0
0
(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection
14
68
2.12
1.74
1.8
2.3
—
—
—
0
0
(3022621) pH of Urine by Test strip
23
134
1.79
1.73
4.7
2.3
—
—
—
0
0
(3016881) Enterovirus RNA [Presence] in Specimen by NAA with probe detection
6
19
3.21
1.67
1.8
2.2
—
—
—
0
0
(3006217) Methemoglobin/Hemoglobin.total in Arterial blood
19
106
1.86
1.64
13.7
6.0
%
0.6
0.7
0.30
19
106
(3051611) Lipemic interference index of Serum or Plasma
5
14
3.62
1.62
5.2
2.8
—
—
—
0
0
(3022145) Colonoscopy Study observation
35
236
1.57
1.56
1.6
1.3
—
—
—
0
0
(40764126) Parainfluenza virus RNA [Presence] in Specimen by NAA with probe detection
5
15
3.38
1.53
1.0
1.3
—
—
—
0
0
(3011648) Oxygen content in Venous blood
5
15
3.38
1.53
3.4
1.8
%
12.0
11.4
—
5
15
(3041354) Potassium [Moles/volume] in Venous blood
6
21
2.90
1.51
2.7
3.0
mmol/l
4.0
3.8
—
6
21
(3033705) Calcium.ionized [Moles/volume] in Venous blood
6
21
2.90
1.51
2.7
3.0
—
—
—
0
0
(3035285) Chloride [Moles/volume] in Venous blood
6
21
2.90
1.51
2.7
3.0
mmol/l
105.8
106.4
—
6
21
(3010566) Parathyrin.intact [Moles/volume] in Serum or Plasma
9
37
2.49
1.49
4.4
2.5
—
—
—
0
0
(3037551) Cancer Ag 125 [Units/volume] in Serum or Plasma
26
165
1.65
1.48
1.5
3.0
u/ml
46.0
53.8
0.15
26
159
(3016251) Hemoglobin.gastrointestinal [Presence] in Stool
16
88
1.88
1.45
2.3
2.3
—
—
—
0
0
(3040363) Hepatitis A virus IgG Ab [Presence] in Serum by Immunoassay
5
16
3.17
1.44
1.0
1.0
—
—
—
0
0
(3028369) Herpes simplex virus 1+2 DNA [Presence] in Specimen by NAA with probe detection
5
16
3.17
1.44
1.0
1.2
—
—
—
0
0
(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection
158
1409
1.36
1.43
3.5
3.3
—
—
—
0
0
(3003327) Ova and parasites identified in Stool by Light microscopy
16
89
1.85
1.41
2.5
1.6
—
—
—
0
0
(3025023) Rhinovirus RNA [Presence] in Specimen by NAA with probe detection
5
17
2.98
1.36
2.0
2.3
—
—
—
0
0
(3049539) Genetic diseases [Identifier] in Blood or Tissue by FISH Nominal
5
17
2.98
1.36
1.2
1.0
—
—
—
0
0
(3015235) Bicarbonate [Moles/volume] in Capillary blood
9
43
2.13
1.32
4.0
3.5
mmol/l
23.7
24.7
—
9
36
(3000855) Microscopic observation [Identifier] in Vaginal fluid by Gram stain
9
43
2.13
1.32
1.4
1.5
—
—
—
0
0
(3028653) Carboxyhemoglobin/Hemoglobin.total in Arterial blood
18
108
1.72
1.26
14.1
6.0
%
1.5
1.5
0.02
18
108
(1761868) Lipid panel - Serum or Plasma
66
812
0.74
1.26
3.0
2.8
—
—
—
0
0
(3024891) Influenza virus A+B Ag [Presence] in Specimen
12
63
1.95
1.25
1.4
1.1
—
—
—
0
0
(3043109) Cytology report of Tissue fine needle aspirate Cyto stain
12
63
1.95
1.25
1.0
1.2
—
—
—
0
0
(3004915) Chlamydophila pneumoniae IgA Ab [Units/volume] in Serum
6
26
2.34
1.19
1.3
1.1
—
—
—
0
0
(3050380) Cytology report of Cervical or vaginal smear or scraping Cyto stain
5
113
0.43
1.16
1.6
1.4
—
—
—
0
0
(3000492) Spirometry study
28
193
1.51
1.15
1.5
1.5
—
—
—
0
0
(3049717) Cytology report of Urine Cyto stain
10
51
2.00
1.13
1.9
2.4
—
—
—
0
0
(3003785) Carcinoembryonic Ag [Mass/volume] in Serum or Plasma
30
214
1.46
1.06
1.7
3.9
ug/l
20.4
9.6
0.26
22
171
(40761536) Microorganisms panel - Urine sediment
26
180
1.50
1.06
9.9
3.7
—
—
—
0
0
(3018251) Fasting glucose [Moles/volume] in Serum or Plasma
188
1989
0.74
1.04
4.7
4.3
mmol/l
5.5
5.8
2.26
179
1840
(3002385) Erythrocyte distribution width [Ratio]
186
1733
1.33
1.04
42.9
15.0
%
14.2
13.6
5.09
186
1706
(3011391) Calcitriol [Moles/volume] in Serum or Plasma
5
22
2.30
1.04
1.0
1.2
—
—
—
0
0
(4306422)
7
34
2.09
1.03
1.4
1.2
—
—
—
0
0
(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)
206
1951
1.40
1.02
28.2
11.1
ml/min/173m2
82.4
83.7
0.33
191
1593
(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection
9
49
1.87
1.00
1.4
1.5
—
—
—
0
0
(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma
179
1663
1.30
0.99
5.2
4.3
pmol/l
14.6
14.6
0.15
172
1533
(4010399)
22
150
1.51
0.97
1.5
1.5
—
—
—
0
0
(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma
14
219
0.62
0.96
1.6
1.7
—
—
—
0
0
(3032155) Metanephrine Free [Moles/volume] in Serum or Plasma
6
27
2.25
0.94
1.3
1.2
—
—
—
0
0
(3013327) Hepatitis A virus IgM Ab [Presence] in Serum
6
27
2.25
0.94
1.0
1.0
—
—
—
0
0
(3030408) 3-Methoxytyramine [Moles/volume] in Serum or Plasma
6
29
2.10
0.90
1.3
1.2
—
—
—
0
0
(3002523) Influenza virus A Ag [Presence] in Specimen
8
42
1.94
0.89
1.0
1.1
—
—
—
0
0
(3003740) Influenza virus B Ag [Presence] in Specimen
8
42
1.94
0.89
1.0
1.1
—
—
—
0
0
(3008152) Bicarbonate [Moles/volume] in Arterial blood
17
112
1.56
0.87
5.7
7.2
mmol/l
25.1
25.3
0.08
17
105
(3021901) Oxygen saturation in Capillary blood
6
31
1.96
0.85
2.5
2.8
—
—
—
0
0
(3020564) Creatinine [Moles/volume] in Serum or Plasma
225
2178
1.56
0.84
37.1
14.0
umol/l
78.7
71.2
1.20
225
2178
(3025839) Triglyceride [Moles/volume] in Serum or Plasma
67
568
1.25
0.78
1.7
1.6
mmol/l
1.4
1.4
0.04
58
484
(3000924) Streptococcus pyogenes [Presence] in Throat by Organism specific culture
0
27
0.00
0.78
0.0
1.3
—
—
—
0
0
(40768795) Lymph node Pathology biopsy report
5
24
2.11
0.75
1.2
1.0
—
—
—
0
0
(3015816) F5 gene p.Arg506Gln [Presence] in Blood or Tissue by Molecular genetics method
7
38
1.87
0.74
1.4
1.1
—
—
—
0
0
(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection
14
92
1.55
0.74
1.8
1.5
—
—
—
0
0
(3042631) Mycobacterium sp identified in Specimen
5
27
1.87
0.69
1.0
3.1
—
—
—
0
0
(3033319) Streptococcus pyogenes Ag [Presence] in Throat
17
234
0.71
0.66
1.8
1.4
—
—
—
0
0
(3019550) Sodium [Moles/volume] in Serum or Plasma
216
2090
1.35
0.65
32.4
13.3
mmol/l
139.4
139.8
1.73
216
2034
(3044889) 12 lead EKG panel
155
1452
1.19
0.62
4.3
3.4
—
—
—
0
0
(3011951) Aspergillus fumigatus IgE Ab [Units/volume] in Serum
0
20
0.00
0.60
0.0
1.1
—
0.1
—
0
9
(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma
225
2194
1.44
0.60
26.6
9.8
u/l
26.1
24.7
0.59
225
2120
(1616796) Gas panel - Central venous blood
6
36
1.68
0.57
2.3
3.0
—
—
—
0
0
(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma
18
238
0.74
0.56
6.2
5.5
—
—
—
0
0
(3044491) Cholesterol non HDL [Mass/volume] in Serum or Plasma
11
159
0.68
0.56
1.5
1.4
—
—
—
0
0
(3023103) Potassium [Moles/volume] in Serum or Plasma
216
2097
1.31
0.56
33.0
13.3
mmol/l
3.9
3.9
0.14
216
2038
(3047181) Lactate [Moles/volume] in Blood
9
61
1.49
0.54
7.3
5.5
mmol/l
1.2
1.1
—
9
55
(40766189) Gliadin peptide IgG Ab [Units/volume] in Serum by Immunoassay
9
61
1.49
0.54
1.1
1.1
—
8.3
—
0
13
(3013290) Carbon dioxide [Partial pressure] in Blood
6
39
1.55
0.53
2.2
2.5
kpa
5.1
5.0
—
6
39
(3027315) Oxygen [Partial pressure] in Blood
6
39
1.55
0.53
2.2
2.5
kpa
7.7
8.7
—
6
39
(3013139) Helicobacter pylori Ag [Presence] in Stool
11
152
0.71
0.46
1.4
1.2
—
—
—
0
0
(3003191) Choriogonadotropin (pregnancy test) [Presence] in Serum or Plasma
8
56
1.44
0.43
1.1
1.9
—
—
—
0
0
(3024666) Lithium, Blood [Moles/volume] in Serum or Plasma
0
15
0.00
0.41
0.0
11.2
—
0.7
—
0
15
(3016650) Hepatitis A virus Ab [Presence] in Serum
5
34
1.48
0.40
1.0
1.1
—
—
—
0
0
(44816844) Macroprolactin [Units/volume] in Serum or Plasma
0
18
0.00
0.40
0.0
1.2
—
—
—
0
0
(44816752) ERBB2 gene copy number/nucleus in Tissue by FISH
0
18
0.00
0.40
0.0
1.1
—
—
—
0
0
(40761511) CBC panel - Blood by Automated count
211
2155
0.82
0.38
27.4
11.5
—
—
—
0
0
(3025941) Bacteria identified in Stool by Culture
16
125
1.30
0.38
1.2
1.2
—
—
—
0
0
(21494755) Public health laboratory ask at order entry panel
20
244
0.80
0.37
1.3
1.3
—
—
—
0
0
(3021387) Prolactin [Units/volume] in Serum or Plasma
9
71
1.28
0.36
2.0
1.3
mu/l
328.9
310.3
—
9
65
(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep
53
474
1.15
0.36
1.7
1.5
—
—
—
0
0
(36032419) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Immunoassay
5
79
0.63
0.36
1.4
1.8
—
—
—
0
0
(3014051) Protein [Presence] in Urine by Test strip
6
44
1.37
0.34
2.5
1.7
—
—
—
0
0
(3008898) HLA-B27 [Presence]
14
109
1.30
0.34
1.0
1.1
—
—
—
0
0
(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection
7
98
0.71
0.31
2.0
1.6
—
—
—
0
0
(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal
15
120
1.27
0.31
1.1
1.0
—
—
—
0
0
(3019832) Treponema pallidum Ab [Presence] in Serum
21
176
1.21
0.30
1.4
1.6
—
—
—
0
0
(3003694) ABO and Rh group [Type] in Blood
50
550
0.89
0.29
1.6
1.4
—
—
—
0
0
(3043409) Potassium [Moles/volume] in Arterial blood
7
57
1.23
0.29
3.1
4.3
mmol/l
3.8
3.8
—
7
50
(3035941) MCH [Entitic mass]
225
2278
0.79
0.29
49.6
18.3
pg
30.2
30.2
0.23
225
2248
(3024731) MCV [Entitic volume]
225
2277
0.80
0.27
49.7
18.3
fl
91.5
91.0
0.73
225
2247
(3002256) Pathology report gross observation
30
263
1.16
0.27
1.3
1.2
—
—
—
0
0
(3004716) Salmonella sp identified in Stool by Organism specific culture
10
127
0.78
0.26
1.2
1.3
—
—
—
0
0
(3014765) Yersinia sp identified in Stool by Organism specific culture
9
77
1.18
0.24
1.2
1.1
—
—
—
0
0
(3035933) Granulocytes/100 leukocytes in Blood
0
11
0.00
0.21
0.0
1.3
—
—
—
0
0
(3000208) Alpha tocopherol [Moles/volume] in Serum or Plasma
0
10
0.00
0.21
0.0
1.7
—
29.2
—
0
10
(3034603) RHD gene allele [Genotype] in Blood or Tissue by Molecular genetics method Nominal
0
10
0.00
0.21
0.0
1.5
—
—
—
0
0
(40757494) Bilirubin.total [Moles/volume] in Blood
0
10
0.00
0.21
0.0
2.2
—
—
—
0
0
(3049506) Microalbumin [Mass/time] in Urine collected for unspecified duration
0
10
0.00
0.21
0.0
1.9
—
—
—
0
0
(3042810) Amyloid beta 42 peptide [Mass/volume] in Cerebral spinal fluid
0
13
0.00
0.21
0.0
1.0
—
482.9
—
0
7
(3000242) Tau protein [Mass/volume] in Cerebral spinal fluid
0
13
0.00
0.21
0.0
1.0
—
276.6
—
0
7
(3008832) Norclozapine [Moles/volume] in Serum or Plasma
0
13
0.00
0.21
0.0
15.6
—
958.8
—
0
13
(40771527) Human papilloma virus E6+E7 mRNA [Presence] in Cervix by NAA with probe detection
0
13
0.00
0.21
0.0
1.8
—
—
—
0
0
(43055225) Phosphorylated tau 181 [Mass/volume] in Cerebral spinal fluid by Immunoassay
0
13
0.00
0.21
0.0
1.1
—
39.4
—
0
7
(3009201) Thyrotropin [Units/volume] in Serum or Plasma
198
1944
1.11
0.20
6.0
5.0
mu/l
2.1
2.4
0.28
189
1801
(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection
11
133
0.82
0.20
1.8
1.7
—
—
—
0
0
(3027238) Thyroperoxidase Ab [Units/volume] in Serum or Plasma
20
176
1.15
0.18
1.4
1.2
iu/ml
126.6
147.8
—
6
79
(4034850)
5
67
0.74
0.17
51.8
6.6
—
—
—
0
0
(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma
207
2041
1.11
0.17
4.8
4.3
mmol/l
1.5
1.6
2.17
199
1892
(43054914) Glucose tolerance 2 hours panel - Serum or Plasma
25
225
1.12
0.17
1.7
1.8
—
—
—
0
0
(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting
199
1960
1.09
0.16
4.5
3.9
mmol/l
1.3
1.3
0.33
193
1807
(3003338) MCHC [Mass/volume]
176
1786
0.94
0.11
43.8
15.7
g/l
329.0
331.5
3.21
176
1779
(3019900) Cholesterol [Moles/volume] in Serum or Plasma
207
2051
1.07
0.09
4.9
4.3
mmol/l
4.5
4.8
4.17
199
1908
(3027944) Amphetamines [Presence] in Urine
6
71
0.84
0.07
1.3
1.3
—
—
—
0
0
(3000764) Benzodiazepines [Presence] in Urine
6
70
0.85
0.07
1.3
1.3
—
—
—
0
0
(3027008) Opiates [Presence] in Urine
6
70
0.85
0.07
1.3
1.3
—
—
—
0
0
(3028300) Cannabinoids [Presence] in Urine
6
70
0.85
0.07
1.3
1.3
—
—
—
0
0
(3020891) Body temperature
6
73
0.82
0.07
4.7
5.1
—
—
—
0
0
(42529406) Shigella sp [Presence] in Stool by Culture
8
78
1.03
0.07
1.4
1.1
—
—
—
0
0
(3006418) Campylobacter sp identified in Tissue by Organism specific culture
8
78
1.03
0.07
1.3
1.1
—
—
—
0
0
(3009542) Hematocrit [Volume Fraction] of Blood
187
1888
0.96
0.07
39.2
12.9
%
36.8
40.1
3.48
135
1446
(3017895) Helicobacter pylori Ab [Units/volume] in Serum
7
81
0.86
0.07
1.7
1.7
—
—
—
0
0
(3021584) Pregnancy associated plasma protein A [Units/volume] in Serum or Plasma
7
85
0.82
0.07
1.6
1.5
—
—
—
0
0
(1002224) Polysomnography panel
11
102
1.08
0.03
1.4
1.1
—
—
—
0
0
(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma
208
2087
0.97
0.01
5.2
4.8
mmol/l
2.6
2.9
3.45
199
1934
(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection
25
248
1.01
0.00
1.6
1.9
—
—
—
0
0
(3013603) Prostate specific Ag [Mass/volume] in Serum or Plasma
25
246
1.02
0.00
3.2
4.5
ug/l
0.9
2.1
2.56
18
222
(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection
22
224
0.98
0.00
1.6
1.8
—
—
—
0
0
(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture
44
438
1.01
0.00
1.4
1.5
—
—
—
0
0
(3027231) Wheat IgE Ab [Units/volume] in Serum
0
8
0.00
0.00
0.0
1.0
—
—
—
0
0
(1001926) Buprenorphine [Presence] in Urine by Screen method
5
55
0.91
0.00
1.4
1.3
—
—
—
0
0
(4198724)
0
8
0.00
0.00
0.0
1.1
—
—
—
0
0
(3040370) OLANZapine [Moles/volume] in Serum or Plasma
0
8
0.00
0.00
0.0
1.6
—
115.6
—
0
8
(3028772) Osteocalcin [Mass/volume] in Serum or Plasma
0
8
0.00
0.00
0.0
3.8
—
—
—
0
0
(3020650) Glucose [Presence] in Urine
0
8
0.00
0.00
0.0
1.5
—
—
—
0
0
(3000213) Normetanephrine [Moles/time] in 24 hour Urine
0
5
0.00
0.00
0.0
1.4
—
1.8
—
0
5
(3002619) Bacteria identified in Specimen by Culture
0
6
0.00
0.00
0.0
1.2
—
—
—
0
0
(3023511) Choriogonadotropin [Units/volume] in Urine
5
52
0.96
0.00
1.0
1.4
—
—
—
0
0
(3037826) lamoTRIgine [Moles/volume] in Serum or Plasma
0
6
0.00
0.00
0.0
1.8
—
14.5
—
0
6
(42869593) Oxyhemoglobin/Hemoglobin.total [Pure mass fraction] in Capillary blood
0
5
0.00
0.00
0.0
1.4
—
—
—
0
0
(3006653) Thiamine [Moles/volume] in Blood
0
9
0.00
0.00
0.0
1.9
—
144.4
—
0
9
(3022058) Hepatitis B virus DNA [Presence] in Serum or Plasma by NAA with probe detection
0
6
0.00
0.00
0.0
1.5
—
—
—
0
0
(4094501)
5
56
0.89
0.00
1.0
1.1
—
—
—
0
0
(44816893) Food Allergen Mix 50 (Kiwi+Pineapple+Banana+Mango) IgE Ab [Units/volume] in Serum by Multidisk
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3039602) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Capillary blood
0
5
0.00
0.00
0.0
1.0
—
1.2
—
0
5
(40758292) HTLV I+II Ab panel - Serum
0
6
0.00
0.00
0.0
1.7
—
—
—
0
0
(3036432) Mycobacterium tuberculosis genotype [Identifier] in Isolate
0
7
0.00
0.00
0.0
7.1
—
—
—
0
0
(3008536) Aspergillus sp Ab [Presence] in Serum
0
6
0.00
0.00
0.0
1.2
—
—
—
0
0
(3016879) Cocaine [Presence] in Urine
6
64
0.94
0.00
1.3
1.3
—
—
—
0
0
(3034988) Calcium [Moles/volume] in Capillary blood
0
7
0.00
0.00
0.0
1.1
—
1.2
—
0
7
Mortality – FinRegistry
↥Association
Association between endpoint DRUGADVERS_SYSTEMIC_LUPUS_ERYTHEMAT and mortality.
Females
| Parameter | HR [95% CI] | p-value |
|---|---|---|
| DRUGADVERS_SYSTEMIC_LUPUS_ERYTHEMAT | 2.507 [2.07, 3.04] | < 0.001 |
| Birth year | 0.993 [0.99, 1.0] | 0.127 |
During the follow-up period (1.1.1998 — 31.12.2019), 239 out of 944 females with DRUGADVERS_SYSTEMIC_LUPUS_ERYTHEMAT died.
Males
| Parameter | HR [95% CI] | p-value |
|---|---|---|
| DRUGADVERS_SYSTEMIC_LUPUS_ERYTHEMAT | 1.985 [1.37, 2.88] | < 0.001 |
| Birth year | 0.991 [0.98, 1.0] | 0.061 |
During the follow-up period (1.1.1998 — 31.12.2019), 82 out of 199 males with DRUGADVERS_SYSTEMIC_LUPUS_ERYTHEMAT died.
Mortality risk
Mortality risk for people of age
years, who have DRUGADVERS_SYSTEMIC_LUPUS_ERYTHEMAT.| N-year risk | Females | Males |
|---|---|---|
| 1 | 0.361% | 0.465% |
| 5 | 1.382% | 2.756% |
| 10 | 3.588% | 6.675% |
| 15 | 6.665% | 12.351% |
| 20 | 11.246% | 20.503% |
Relationships between endpoints
↥Index endpoint: DRUGADVERS_SYSTEMIC_LUPUS_ERYTHEMAT – Drug-induced systemic lupus erythematosus
GWS hits: 1
Endpoint
Case Overlap
Survival Analysis
Genetic Correlations
Genetic Signals
N (Jaccard index)
HR [CI]
rg [CI]
Hits
Coloc Hits
FinRegistry
FinnGen
FinRegistry
FinnGen
FinnGen
Loading data